Pharmacokinetic-pharmacometabolomic approach in early-phase clinical trials: A way forward for targeted therapy in type 2 diabetes
Pharmacometabolomics in early phase clinical trials demonstrate the metabolic profiles of a subject responding to a drug treatment in a controlled environment, whereas pharmacokinetics measure the drug plasma concentration in human circulation. Application of the personalized peak plasma concentrati...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/41969/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universiti Malaya |